KALA - Kala Pharmaceuticals Inc. (KALA) CEO Mark Iwicki on Q4 2018 Results - Earnings Call Transcript
Kala Pharmaceuticals, Inc. (KALA)
Q4 2018 Earnings Conference Call
March 11, 2019 4:30 p.m. ET
Company Participants
Mary Reumuth - CFO
Mark Iwicki - Chairman, President, CEO
Kim Brazzell - Chief Medical Officer
Todd Bazemore - COO
Hongming Chen - Chief Scientific Officer
Conference Call Participants
David Maris - Wells Fargo
Liana Moussatos - Wedbush Securities
Yi Chen - H.C. Wainwright
Presentation
Operator
Good day, and welcome to Kala Pharmaceuticals Fourth Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, a Q&A session will be